Invasive procedures to biopsy tissue from cancer-tainted organs could be replaced by simply taking samples from a tiny “decoy” implanted just beneath the skin, University of Michigan researchers have demonstrated in mice.
These devices have a knack for attracting cancer cells traveling through the body. In fact, they can even pick up signs that cancer is preparing to spread, before cancer cells arrive.
“Biopsying an organ like the lung is a risky procedure that’s done only sparingly,” said Lonnie Shea, the William and Valerie Hall Chair of biomedical engineering at U-M. “We place these scaffolds right under the skin, so they’re readily accessible.”
The ease of access would also allow doctors to monitor the effectiveness of cancer treatments closer to real time.
The U-M team’s most recent work appears in Cancer Research, a publication of the American Association for Cancer Research.
Biopsies of the scaffold allowed researchers to analyze 635 genes present in the captured cancer cells. From these genes, the team identified ten that could predict whether a mouse was healthy, if it had a cancer that had not begun to spread yet, or if a cancer was present and had begun to spread. They could do that all without the need for an invasive biopsy of an organ.
The gene expression obtained at the scaffold had distinct patterns relative to cells from the blood, which are obtained through a technique known as liquid biopsy. These differences highlight that the tissue in these traps provides unique information that correlates with disease progression.
The researchers have demonstrated that the synthetic scaffolds work with multiple types of cancers in mice, including pancreatic cancer. They work by luring immune cells, which, in turn, attract cancer cells.
“When we started off, the idea was that we would biopsy the scaffold and look for tumor cells that had followed the immune cells there,” Shea said. “But we realized that by analyzing the immune cells that gather first, we can detect the cancer before it’s spreading.”
In treating cancer, early detection is key.
“Currently, early signs of metastasis can be difficult to detect,” said Jacqueline Jeruss, an associate professor of surgery and biomedical engineering and a co-author of the study. “Imaging may be done once a patient experiences symptoms, but that implies the number of cancer cells may already be substantial. Improved detection methods are needed to identify metastasis at a point when targeted treatments can have a significant beneficial impact on slowing disease progression.”
The immune cells allowed researchers to identify whether treatments were effective in the mice and which subjects were sensitive or resistant to treatment.
The decoy’s ability to draw immune and cancer cells can also bolster the treatment itself. In previous research, the devices demonstrated an ability to slow the growth of metastatic breast cancer tumors in mice, by reducing the number of cancer cells that can reach those tumors.
In the future, Shea envisions that the scaffolds could be outfitted with sensors and Bluetooth technology that could deliver information in real time without the need for a biopsy.
The Latest on: Biopsies
via Google News
The Latest on: Biopsies
- Motley Fool: Healthy profits for Guardant Healthon February 23, 2020 at 12:11 am
Guardant Health (Nasdaq: GH) gained 108% last year, enough to land a spot among the top health care stocks of 2019. Its success stemmed from rapidly growing sales of Guardant360 and GuardantOMNI – ...
- A hard fall unmasked an unusual condition that had caused her pain for yearson February 22, 2020 at 8:00 am
For years, Holland’s doctors had disagreed about what was wrong with her hip. She had undergone a slew of scans, plus painful biopsies of her hip bones. Her doctors had prescribed cortisone injections ...
- Dr. Levy on the Current State of Liquid Biopsies Across Tumor Typeson February 21, 2020 at 3:27 pm
Benjamin P. Levy, MD, assistant professor of oncology and clinical director of Medical Oncology, Sidney Kimmel Cancer Center, Johns Hopkins Medicine, discusses the current state of liquid biopsies ...
- What's Included in the Diagnosis and Staging of CLL?on February 21, 2020 at 8:52 am
It’s leukemia, did he need a bone marrow biopsy to be done? Was there a CT [computed tomography] scan of his belly? All those things, including lymph node biopsies. Ian W. Flinn, M.D., Ph.D.: In ...
- Dr. Lopategui on the Use of Liquid Biopsies in Lung Canceron February 20, 2020 at 1:27 pm
Jean Lopategui, MD, associate professor of pathology and director of Translational Genomics and of the Molecular Genetics Pathology Fellowship at Cedars-Sinai, discusses the use of liquid biopsies in ...
- Hyperproliferation is the main driver of metabolomic changes in psoriasis lesional skinon February 20, 2020 at 4:02 am
Here we compared for the first time the full metabolomic profiles of lesional and non-lesional skin biopsies obtained from plaque psoriasis patients and skin samples of healthy controls. Significant ...
- Carlisle family shares their Four Diamonds story: Participating in Thon is ‘a feeling you can’t describe’on February 20, 2020 at 2:37 am
After a 14 day hospital stay and three biopsies, the ten-year-old was diagnosed with stage 3 rhabdomyosarcoma, a rare form of childhood cancer, much to the surprise of the whole family. “We never ...
- Hybrid optical and IR microscope promises faster digital biopsieson February 19, 2020 at 7:00 am
A project at the University of Illinois at Urbana-Champaign (UIUC) has demonstrated how an infrared-optical hybrid (IR-OH) microscope could enable all-digital biopsy workflows to be developed for a ...
- Illumina Spinoff GRAIL to Trial Liquid Biopsies for Early Detection of Canceron February 16, 2020 at 4:00 pm
Companies including QIAGEN, RainDance, and Genomic Health are all working to commercialize liquid biopsies as alternatives to more invasive cancer testing. None, however, have demonstrated that liquid ...
- Digital biopsies: coming soon to clinics near youon February 16, 2020 at 4:43 am
"For more than a century, we have relied on adding dyes to human tissue biopsies to diagnose tumors. However, the shape and color induced by the dye provide very limited information about the ...
via Bing News